Diabetes News

People who ate a mostly plant-based diet reduced their risk of diabetes by 23%, the study found.

Diabetes brings with it a variety of long-term complications, but at least one of those -- heart failure -- is a bigger threat to women than men, new research suggests.

Insulin prices have skyrocketed in recent years, putting diabetes patients who desperately need it in a bind.

The FDA has recalled certain Medtronic MiniMed insulin pumps because there’s a risk of them being hacked, the agency said.

The data suggest a need for even better blood sugar management in children with type 1 diabetes, but kids in the study were -- on average -- doing well in and out of school, one researcher noted.

After nearly three years, 24.2% of those taking vitamin D developed diabetes, as did 26.7% of those taking the placebo. This difference isn't statistically significant, researchers said.

People who had type 2 diabetes in their 40s or 50s had a 30% greater chance of a stroke caused by a blood clot, researchers said.

The study findings suggest it might be more important to control other risk factors for heart disease, such as high blood pressure, cholesterol and unhealthy weight.

Possible reasons for the decline include changes in testing and getting people to make healthy lifestyle changes before they develop diabetes, the AP reported.

The company's generic version of its Humalog U-100 is being sold under the chemical name insulin lispro,

The genes identified in the study and the proteins they encode are potential targets for new diabetes medicines, and may help improve understanding and treatment of the disease, according to the study authors.

Popular diabetes drugs known as SGLT2 inhibitors are linked with an increased risk of developing a flesh-eating bacteria that attacks the genitals, a rare condition known as Fournier gangrene.

Metformin doesn't seem to be particularly helpful for shedding pounds in the first place, though.

Pre-owned test strips or test strips not authorized for sale in the United States may be sold online through Amazon, eBay and Craigslist, or directly from the seller, according to the FDA.

Those who took Invokana had a 30% lower risk of developing kidney failure, a 30% lower risk of dying from kidney failure or heart disease, the researchers reported.

During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.

The average price of insulin rose from about $234 a month in 2012 to about $450 a month in 2016, according to the Health Cost Institute.

People who've had diabetes for a long time are at risk of developing hypoglycemia unawareness: They no longer feel the uncomfortable warning symptoms of low blood sugar.

There are three types of blood tests that can be used to look for diabetes -- the A1C, a fasting blood test or a random blood test, according to the U.S. National Institute for Diabetes and Digestive and Kidney Diseases.

Drug Maker To Sell Cheaper Version of Insulin March 4, 2019 -- A cheaper version of Eli Lilly's most popular insulin drug, Humalog, is being introduced by the drug maker.The "authorized generic" of Humalog 100 will sell for $137.35 per vial, 50 percent lower than the list price for Humalog. An authorized generic is identical to the brand-name drug and made in the same facilities, but just has a different label, The New York Times reported Monday.The new product will be called Insulin Lispro and will become available as soon as possible, according to the company.The move

Eating five or more weekly servings of nuts also appears to lower the risk of premature death from heart disease or any other cause by about one-third for people with type 2 diabetes.

The surgery isn't necessarily a cure for type 2 diabetes. Some people who go into remission and appear to no longer have the disease can relapse and start having symptoms again.

A new British study confirms that dogs can detect dangerous variations in a person's blood sugar.

The annual amount that people with type 1 diabetes spent on the drug rose from about $2,900 in 2012 to about $5,700 in 2016, according to a new analysis from the nonprofit Health Care Cost Institute (HCCI).

Over the three years of tracking the time between their last meal and sleep, there was no significant change in study participants' HbA1c levels -- a long-term measure of average blood glucose that is considered a reliable indicator of future health risks.